SUBSCRIBE
SUBSCRIBE
News   Drug Development

AstraZeneca PLC (JOBS), Sanofi (France) (JOBS), Merck & Co., Inc. Heart Drugs Cut Alzheimer’s Disease

January 14, 2010 | 
1 min read
Bookmark and Share

Bloomberg -- Drugs commonly used to lower blood pressure, sold by AstraZeneca Plc, Sanofi-Aventis SA and Merck & Co., may also reduce the risk of developing Alzheimer’s disease.
Clinical research Phase III Postmarket research
AstraZeneca Pharmaceuticals LP Merck & Co. Sanofi (France)
MORE ON THIS TOPIC
Podcast
Pfizer Wins Metsera, Trump Strikes GLP-1 Pricing Deal, FDA Awards More Priority Vouchers
November 12, 2025
 · 
1 min read
 · 
Heather McKenzie
3d rendering medical heart in yellow background
Cardiovascular disease
Amgen, Merck, Novo, More Take Cardiovascular Benefits to New Heights at AHA 2025
November 11, 2025
 · 
5 min read
 · 
Tristan Manalac
Unhappy young woman feel lonely abandoned in crowd suffer from communication lack. Upset girl struggle with depression or mental disorder. Psychological problem. Flat vector illustration.
Depression
Neurocrine’s Depression Drug Delivers ‘Surprise’ Phase II Miss
November 11, 2025
 · 
2 min read
 · 
Tristan Manalac
Changing or transforming, turning around, challenging the odds and conquering adversity, a businessman pole vaulting from the down arrow to the up arrow of growth
Cancer
Cogent Hits ‘Unprecedented’ Efficacy in Rare Stomach Cancer, Clearing Path to FDA
November 11, 2025
 · 
2 min read
 · 
Tristan Manalac